Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jul;50(1):109–111. doi: 10.1038/bjc.1984.145

Assignment of the gene encoding for Meth A tumour rejection antigen (TATA) to chromosome 12 of the mouse.

L W Law
PMCID: PMC1976936  PMID: 6743507

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DeLeo A. B., Chang K. S., Wivel N. A., Appella E., Old L. J., Law L. W. possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma. Int J Cancer. 1982 Jun 15;29(6):687–693. doi: 10.1002/ijc.2910290615. [DOI] [PubMed] [Google Scholar]
  2. DeLeo A. B., Shiku H., Takahashi T., John M., Old L. J. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J Exp Med. 1977 Sep 1;146(3):720–734. doi: 10.1084/jem.146.3.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DuBois G. C., Appella E., Law L. W., DeLeo A. B., Old L. J. Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells. Cancer Res. 1980 Nov;40(11):4204–4208. [PubMed] [Google Scholar]
  4. DuBois G. C., Appella E., Law L. W., DeLeo A. B., Old L. J. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA). Transplant Proc. 1981 Dec;13(4):1765–1773. [PubMed] [Google Scholar]
  5. DuBois G. C., Law L. W., Appella E. Purification and biochemical properties of tumor-associated transplantation antigens from methylcholanthrene-induced murine sarcomas. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7669–7673. doi: 10.1073/pnas.79.24.7669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Natori T., Law L. W., Appella E. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma. Cancer Res. 1977 Sep;37(9):3406–3413. [PubMed] [Google Scholar]
  7. Pellis N. R., Kahan B. D. Specific tumor immunity induced with soluble materials: restricted range of antigen dose and of challenge tumor load for immunoprotection. J Immunol. 1975 Dec;115(6):1717–1722. [PubMed] [Google Scholar]
  8. Pravtcheva D. D., DeLeo A. B., Ruddle F. H., Old L. J. Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma. J Exp Med. 1981 Sep 1;154(3):964–977. doi: 10.1084/jem.154.3.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ransom J. H., Schengrund C. L., Bartlett G. L. Solubilization and partial characterization of a tumor-rejection antigen from an ultraviolet light-induced murine tumor. Int J Cancer. 1981;27(4):545–554. doi: 10.1002/ijc.2910270419. [DOI] [PubMed] [Google Scholar]
  10. Rogers M. J., Law L. W. Some immunogenic acid biochemical properties of tumor-associated transplantation antigens (TATA) obtained in soluble form or solubilized from two methylcholanthrene-induced sarcomas, Meth A and CI-4. Int J Cancer. 1981 Jun 15;27(6):789–796. doi: 10.1002/ijc.2910270610. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES